CN Patent

CN108610338A — 一种嘧啶酮酰胺类化合物的制备方法

Assigned to TIANJIN INTERNATIONAL JOINT ACADEMY OF BIOMEDICINE · Expires 2018-10-02 · 8y expired

What this patent protects

本发明公开了一种嘧啶酮酰胺类化合物及其制备方法,以嘧啶酮化合物为起始原料,经过四步化学转化得到TN‑A005及其类似物,中间体可以使用甲基四氮唑制备得到,整个制备过程中用到了一锅法投料并且每一步的后处理纯化为重结晶或分散洗涤,避免了使用硅胶柱层析等手段,极大地简化了制备工艺以及提高了制备效率,且总收率可达50%。该方法不仅制备步骤简便,还能提高制备效率。

USPTO Abstract

本发明公开了一种嘧啶酮酰胺类化合物及其制备方法,以嘧啶酮化合物为起始原料,经过四步化学转化得到TN‑A005及其类似物,中间体可以使用甲基四氮唑制备得到,整个制备过程中用到了一锅法投料并且每一步的后处理纯化为重结晶或分散洗涤,避免了使用硅胶柱层析等手段,极大地简化了制备工艺以及提高了制备效率,且总收率可达50%。该方法不仅制备步骤简便,还能提高制备效率。

Drugs covered by this patent

Patent Metadata

Patent number
CN108610338A
Jurisdiction
CN
Classification
Expires
2018-10-02
Drug substance claim
No
Drug product claim
No
Assignee
TIANJIN INTERNATIONAL JOINT ACADEMY OF BIOMEDICINE
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.